Switching from tenofovir disoproxil fumarate to tenofovir alafenamide coformulated with rilpivirine and emtricitabine in virally suppressed adults with HIV-1 infection: a randomised, double-blind, multicentre, phase 3b, non-inferiority study

C Orkin, E DeJesus, M Ramgopal, G Crofoot, P Ruane, A LaMarca, A Mills, B Vandercam, J de Wet, J Rockstroh, A Lazzarin, Bart Rijnders, D Podzamczer, A Thalme, M Stoeckle, D Porter, HC Liu, A Cheng, E Quirk, D SenGuptaH Cao

Research output: Contribution to journalArticleAcademicpeer-review

56 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)E195-E204
JournalLANCET HIV
Volume4
Issue number5
DOIs
Publication statusPublished - 2017

Cite this